Microscopic photo from National Cancer Institute

Sector group

Life sciences

HGF’s life sciences attorneys understand the challenges associated with commercially focused IP management and can advise on the pertinent issues, from invention conception through to patent term extension, to maximise the value of intellectual property.

Lady looking into test tube

As one of Europe’s largest groups of specialist life science attorneys, HGF has the wealth of technical and legal expertise to deliver truly global, commercially-focused strategies.

From protecting new research from Europe’s most prestigious universities, to high-profile oppositions for international healthcare companies on market-leading technologies, the team possesses in-depth legal experience. Particular technical expertise within the group covers the fields of food technology, microbiome for therapeutic purposes, cell and gene therapy, bioinformatics, cleantech, AgBio, immunobiology, gene editing technologies, personalised medicine, bioprocessing and anti-infectives.

In addition, our life sciences attorneys work closely with our IP lawyers in relation to life cycle agreements such as MTAs, R&D collaborations, companion diagnostics, IP licensing, clinical trials through to commercial manufacturing and supply, and litigation.

Latest updates

HGF ranked in the Financial Times special report 2021

HGF has been ranked in the Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on the 17th June 2021. More than 10,000 patent attorneys working in patent law …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

HGF continues its European expansion with the opening of a new business in France

HGF launched the next phase of its European expansion with the opening of its new business in France based in its 22nd European office, in Rennes, France. The office will …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article

This is not just any caterpillar...

It would have been difficult to miss the recent news that Marks & Spencer has filed trade mark infringement proceedings against German discounter Aldi’s Cuthbert the Caterpillar cake. The filing …

Read article

EPO continues oral proceedings by videoconference in examination and opposition during pendency of referral G 1/21

The EPO Boards of Appeal took the decision that from the start of 2021, all Boards of Appeal oral proceedings could be held by videoconference, even if the parties to …

Read article

Notice from the European Patent Office dated 22 February 2021 concerning the amendment of Rules 19 and 143 EPC

From 1 April 2021, inventors will no longer be notified by the EPO about being named in a patent application. In addition, applicants will no longer be required to indicate …

Read article

Patentability of Computer Simulations in Europe (G 01/19)

The long expected decision of the Enlarged Board of Appeal (G 01/19) has been announced by the EPO. The decision relates to the question whether computer simulations can be patented …

Read article